Nobilis Health Corp. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, total revenue was $64,652,000 against $70,683,000 a year ago. Profit from operations was $1,283,000 against loss of $1,101,000 a year ago. Net loss before income taxes and non-controlling interests was $69,000 against $1,780,000 a year ago. Net income attributable to the company was $1,014,000 against loss of $2,759,000 a year ago. Net income per fully diluted common share was $0.01 against loss of $0.04 diluted common per share a year ago. EBITDA was $5,133,000 against $499,000 a year ago. Adjusted EBITDA was $6,715,000 against $4,337,000 a year ago. Improvements in operating efficiencies and lower corporate cost are contributing to this overall improvement. Cash provided by operating activities for the quarter was $10.6 million compared to $900,000 in third quarter of 2016.

For the nine months, total revenue was $212,916,000 against $183,827,000 a year ago. Profit from operations was $5,533,000 against loss of $10,740,000 a year ago. Net income before income taxes and non-controlling interests was $1,678,000 against loss of $8,278,000 a year ago. Net income attributable to the company was $201,000 against loss of $2,918,000 a year ago. Net cash provided by operating activities was $27,883,000 against $8,303,000 a year ago, driven primarily by the improvement in overall profitability. Purchase of property and equipment was $4,470,000 against $2,898,000 a year ago. EBITDA was $12,865,000 against $4,102,000 a year ago. Adjusted EBITDA was $18,781,000 against $13,198,000 a year ago.

With the impact of the storm in third quarter and the uncertainty of the impact in fourth quarter, the company is narrowing its guidance to the low end of its previously announced range of $310 million to $325 million, and adjusted EBITDA of $40 million to $45 million.